Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 078688

Expand all

NADOLOL AND BENDROFLUMETHIAZIDE (BENDROFLUMETHIAZIDE; NADOLOL)
5MG;40MG
Marketing Status: Discontinued

Active Ingredient: BENDROFLUMETHIAZIDE; NADOLOL
Proprietary Name: NADOLOL AND BENDROFLUMETHIAZIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 5MG;40MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A078688
Product Number: 001
Approval Date: Feb 15, 2008
Applicant Holder Full Name: MYLAN PHARMACEUTICALS INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

NADOLOL AND BENDROFLUMETHIAZIDE (BENDROFLUMETHIAZIDE; NADOLOL)
5MG;80MG
Marketing Status: Discontinued

Active Ingredient: BENDROFLUMETHIAZIDE; NADOLOL
Proprietary Name: NADOLOL AND BENDROFLUMETHIAZIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 5MG;80MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A078688
Product Number: 002
Approval Date: Feb 15, 2008
Applicant Holder Full Name: MYLAN PHARMACEUTICALS INC
Marketing Status:  Discontinued
Patent and Exclusivity Information